| 别名 | ; |
2,6-二溴-9,10-二(2-萘基)蒽
2,6-Dibromo-9,10-di(2-naphthyl)anthracene （订货以英文为准）
编号：D155105
CAS号：561064-15-1
分子式：C34H20BR2
分子量：588.33
| 产品名称 | 2,6-Dibromo-9,10-di(2-naphthyl)anthracene |
| 中文名称 | 2,6-二溴-9,10-二(2-萘基)蒽 |
| CAS号 | 561064-15-1 |
| MDL编码 | D155105 |
| 分子式（M.F.） | C34H20BR2 |
| 分子量（M.W.） | 588.33 |
| 储存条件 | 室温 |
| Reaxys-RN | 5109154 |
技术规格
| Background: | Receptor for EGF, but also for other members of the EGF family, as TGF-alpha, amphiregulin, betacellulin, heparin-binding EGF-like growth factor, GP30 and vaccinia virus growth factor. Is involved in the control of cell growth and differentiation. Phosphorylates MUC1 in breast cancer cells and increases the interaction of MUC1 with SRC and CTNNB1/beta-catenin. |
| Applications: | WB, IHC |
| Name of antibody: | EGFR (Phospho-Tyr1197) |
| Immunogen: | Synthetic peptide of human EGFR (Phospho-Tyr1197) |
| Full name: | epidermal growth factor receptor (Phospho-Tyr1197) |
| Synonyms： | ERBB; HER1; mENA; ERBB1; PIG61 |
| SwissProt: | P00533 |
| IHC positive control: | Human breast carcinoma |
| IHC Recommend dilution: | 50-100 |
| WB Predicted band size: | 175 kDa |
| WB Positive control: | HUVEC cells untreated or treated with EGF |
| WB Recommended dilution: | 500-1000 |
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 411.90
C196274-5g
党沛 
